Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecast to 2025
[190 Pages Report] The market for blood culture tests is expected to grow from USD 4.0 billion in 2020 to USD 6.1 billion by 2025, at a CAGR of 8.9% during the forecast period. Growth in the blood culture tests market is attributed to factors such as increasing number of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growth in the demand for rapid diagnostic techniques, and the high prevalence of infectious diseases.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the Global Blood Culture Tests Market
The COVID-19 pandemic that began in Wuhan, China, has caused significant disruptions to businesses and economic activities worldwide. COVID-19 is expected to have a negative impact on the blood culture tests market due to the limited or non-availability of medical facilities/treatment centers. To reduce the strain on the healthcare system and decrease disease transmission, governments worldwide are providing guidelines to postpone or delay non-essential medical and surgical procedures. Restrictions and lockdowns were also imposed in the areas of travel, business operations, public gatherings, health clubs, and fitness/wellness centers.
The COVID-19 pandemic has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for manufacturers. Numerous manufacturers found themselves in situations where demand greatly exceeded supply, and therefore, many laboratories struggled to continue to offer testing in some areas. This negatively affected the blood culture tests market.
Blood Culture Tests Market Dynamics
Driver: High incidence of blood stream infec tions
Nosocomial (hospital-acquired) bloodstream infections are one of the leading causes of mortality across the globe. In the US alone, approximately 250,000 cases of hospital-acquired BSIs occur each year. Globally, bloodstream infections affect about 30 million people leading to 6 million deaths, with 3 million newborns and 1.2 million children suffering from sepsis annually. In Eastern African countries, the proportion of patients with bloodstream infections is reported to range from 11% to 28%. In Ghana, bloodstream infection rates are estimated to be in the range of 9.3% to 11.2% (Source: Journal of Tropical Medicine, 2019). The occurrence of these infections increases the overall duration of hospitalization as well as the cost of treatment. With the high incidence of BSIs, the demand for advanced blood culture techniques that help in the early detection of infections is expected to increase.
Restraint : High cost of automated instruments
Automated blood culture instruments are equipped with advanced features and functionalities and thus are priced at a premium. The cost of automated instruments such as PCR is around USD 10,000 to USD 15,000, and that of MALDI-TOF MS systems is around USD 150,000 to USD 850,000. Academic research laboratories generally cannot afford such high-cost systems as they have limited budgets. In addition, the maintenance costs and several other indirect expenses result in an increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of automated blood culture instruments, especially among small-scale end users.
Challenge: Market cannibalization
In recent years, several technologically advanced products that provide enhanced solutions for the detection of microorganisms present in the bloodstream have been launched in the market. These advanced products are expected to cannibalize the market for conventional products, such as microscopes and polystainers, thereby affecting the growth of conventional blood culture testing products. In order to maintain a competitive position in the market, players will have to diversify their product portfolio by adopting new technologies. This will be a challenging task for market players who have an established portfolio of conventional products..
Opportunity:Emerging Economies
Emerging economies such as China, India, and other countries in Southeast Asia and countries in the Middle East and Latin America are becoming focal points for the growth of the blood culture tests market. The high growth in these markets can primarily be attributed to the growth in the prevalence of infectious diseases, rapid growth in the geriatric population, the growing number of product approvals, and rising healthcare expenditure. For instance, the healthcare expenditure in China increased to 5.35% of the GDP in 2018 from USD 4.88% of GDP in 2015 (Source: World Bank, OECD). Such significant spending will result in the adoption of advanced systems, such as automated blood culture systems, among hospital and reference laboratories in these regions. This, in turn, is expected to provide potential growth opportunities for players operating in the blood culture tests market in the coming years.
“By product, the consumables segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of product, the blood culture tests market is segmented into consumables, instruments, and software and services. Consumables is the largest and fastest-growing segment, in 2019. This segment is also projected to register the highest CAGR from 2020 to 2025. The recurring requirement of consumables as compared to instruments is the key factor driving the growth of this segment..
“By application, bacteremia accounted for the largest share of the diagnostic applications market in 2019”
On the basis of d applications, the blood culture tests market is segmented into bacteremia, fungemia, and mycobacterial detection. Among these application segments, bacteremia accounted for the largest market share of in 2019. This segment is also expected to grow at the highest CAGR during the forecast period. The large share of this segment is primarily attributed to the increasing number of bloodstream infections and the growing number of sepsis cases worldwide.
By method, conventional/manual blood culture method accounted for the largest share of the blood cultue tests market in 2019
Based on method, the blood culture tests market is segmented into conventional/manual blood culture and automated blood culture methods. In 2019, the conventional/manual blood culture methods segment accounted for the largest share of the blood culture tests market. However, the automated blood culture methods segment is expected to register the highest CAGR during the forecast period. The quick turnaround time and reduced risk of contamination due to low manual intervention are the key factors contributing to market growth.
North America accounted for the largest share of the blood culture tests market in 2019, while the Asia Pacific market is expected to register the highest growth during the forecast period
The blood culture tests market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of of the global blood culture tests market in 2019. However, the Asia Pacific market is expected to register the highest CAGR during the forecast period.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The major players in the blood culture tests market are Becton, Dickinson and Company (US), bioMérieux SA (France), and Thermo Fisher Scientific Inc. (US). These companies together accounted for a share of more than 60% of the blood culture tests market in 2019. Other players in the market include Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (a subsidiary of Abbott Laboratories) (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India)among others.
Scope of Market
|
Report Metric |
Details |
|
Market Size Available for Years |
2018–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2025 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Method, Product, Technology, Application, End User and Region |
|
Geographies Covered |
North America (US and Canada), Europe (Germany, France, UK, Italy, Spain and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa |
|
Companies Covered |
Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India). |
This research report categorizes the blood culture tests market into the following segments:
Blood culture tests Market, by Method
- Conventional/Manual Methods
- Automated Methods
Blood culture tests Market, by Product
- Consumables
- Blood Culture Media
- Aerobic Blood Culture Media
- Pediatric Aerobic Blood Culture Media
- Anaerobic Blood Culture Media
- Mycobacterial Blood Culture Media
- Fungi/Yeast Blood Culture Media
- Assay Kits & Reagents
- Blood Culture Accessories
- Blood Culture Media
- Instruments
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Incubators
- Colony Counters
- Microscopes
- Gram Stainers
- Software and Services
Blood culture tests Market, by Technology
- Culture-Based Technology
- Molecular Technologies
- Microarrays
- PCR (Polymerase Chain Reaction)
- PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ Hybridization)
- Proteomics Technology
Blood culture tests Market, by Application
- Bacteremia
- Fungemia
- Mycobacterial Detection
Blood culture tests Market, by End User
- Hospital Laboratories
- Reference Laboratories
- Academic Research Laboratories
- Other Laboratories
Blood culture tests Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments:
- In 2020, Becton, Dickinson and Company (US), had an agreement with Babson Diagnostics (US).The companies signed an agreement to enable small-volume blood collection for diagnostic testing in retail settings.
- In 2019, bioMérieux SA (France), partnerd with Wellcome Trust (UK), to coordinate VALUE-Dx, a European public-private partnership to fight antimicrobial resistance through diagnostics.
- In 2018, bioMérieux SA (France), received FDA clearance for BPA and BPN culture bottles used with BACT/ALERT VIRTUO for the quality control testing of platelets
Frequently Asked Questions (FAQ):
Which product segment will dominate the blood culture tests market in the future?
The consumables segment will dominate the blood culture tests market in the future
Emerging countries have immense opportunities for the growth and adoption of blood culture tests; will this scenario continue in the next five years?
Asia Pacific is expected to register the highest CAGR during the forecast period, emerging markets such as China and India are witnessing growth due to the increasing healthcare expenditure. This has resulted in the increasing acceptance of advanced systems in the Asia Pacific region.
Other factors such as large patient population (leading to more surgeries, invasive medical procedures, and infectious diseases); increasing cases of sepsis, bloodstream infections, and tuberculosis; poor adherence to infection control guidelines leading to greater chances of developing bloodstream infections; growing elderly population (especially in Japan); increasing healthcare expenditure; and increasing awareness about sepsis are contributing to the growth of the blood culture tests market in the Asia Pacific.
Who are the leading players in the blood culture tests market?
Prominent players in the market are Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).
What are the major end users in the blood culture tests market?
The blood culture tests market is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories (includes pathology laboratories, bacteriological laboratories, physician office laboratories, and independent research laboratories). .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 GROWTH FORECAST
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 4 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 40)
FIGURE 5 BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 6 BLOOD CULTURE TESTS MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
FIGURE 7 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 8 BLOOD CULTURE TESTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 9 BLOOD CULTURE TESTS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 44)
4.1 BLOOD CULTURE TESTS MARKET OVERVIEW
FIGURE 10 RISING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD & COUNTRY (2019)
FIGURE 11 CONVENTIONAL/MANUAL BLOOD CULTURE METHODS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
4.3 BLOOD CULTURE TESTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 12 ASIA PACIFIC COUNTRIES TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 47)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 13 BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing number of sepsis cases and high cost of treatment
TABLE 1 US: FIVE MOST EXPENSIVE CONDITIONS TREATED IN HOSPITALS
5.2.1.2 Rising geriatric population
TABLE 2 GERIATRIC POPULATION: KEY STATISTICS
5.2.1.3 High incidence of bloodstream infections
5.2.1.4 Growing demand for rapid diagnostic techniques
5.2.1.5 High prevalence of infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 High cost of automated instruments
5.2.2.2 Lack of trained laboratory technicians
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Identification of antibiotic-resistant microorganisms
5.2.4 CHALLENGES
5.2.4.1 Market cannibalization
5.2.4.2 Survival of new entrants
5.2.5 TRENDS
5.2.5.1 Laboratory automation for increased efficiency and accurate diagnosis
5.3 VALUE CHAIN ANALYSIS
FIGURE 14 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.4 ECOSYSTEM ANALYSIS OF THE BLOOD CULTURE PRODUCTS MARKET
FIGURE 15 ECOSYSTEM ANALYSIS
5.5 COVID-19 IMPACT ON THE BLOOD CULTURE TESTS MARKET
6 BLOOD CULTURE TESTS MARKET, BY METHOD (Page No. - 55)
6.1 INTRODUCTION
TABLE 3 BLOOD CULTURE TESTS MARKET, BY METHOD, 2018–2025 (USD MILLION)
6.2 CONVENTIONAL/MANUAL BLOOD CULTURE
6.2.1 CONVENTIONAL/MANUAL BLOOD CULTURE METHODS ACCOUNT FOR THE LARGER SHARE OF THE MARKET
TABLE 4 EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
TABLE 5 CONVENTIONAL/MANUAL BLOOD CULTURE METHODS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 AUTOMATED BLOOD CULTURE
6.3.1 AUTOMATED BLOOD CULTURE METHODS SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 6 EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
TABLE 7 AUTOMATED BLOOD CULTURE METHODS MARKET, BY REGION, 2018–2025 (USD MILLION)
7 BLOOD CULTURE TESTS MARKET, BY PRODUCT (Page No. - 60)
7.1 INTRODUCTION
TABLE 8 BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
7.2 CONSUMABLES
TABLE 9 BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 BLOOD CULTURE CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1 BLOOD CULTURE MEDIA
TABLE 11 EXAMPLES OF BLOOD CULTURE MEDIA
TABLE 12 BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 13 BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1.1 Aerobic blood culture media
7.2.1.1.1 Aerobic blood culture media is the fastest-growing segment of the blood culture media market
TABLE 14 AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1.2 Pediatric aerobic blood culture media
7.2.1.2.1 This type of culture media is used to recover pathogens from the bloodstream of children
TABLE 15 PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1.3 Anaerobic blood culture media
7.2.1.3.1 Anaerobic microorganisms account for 1—17% of the positive blood cultures
TABLE 16 ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1.4 Mycobacterial blood culture media
7.2.1.4.1 Rising prevalence of tuberculosis to drive market growth
TABLE 17 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.1.5 Fungi/yeast blood culture media
7.2.1.5.1 Fungi/yeast blood culture media is used to detect fungemia
TABLE 18 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 ASSAY KITS & REAGENTS
7.2.2.1 Reagents are key components of conventional blood culture tests
TABLE 19 EXAMPLES OF BLOOD CULTURE ASSAY KITS
TABLE 20 ASSAY KITS & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 BLOOD CULTURE ACCESSORIES
7.2.3.1 Growing number of blood culture tests to support market growth
TABLE 21 EXAMPLES OF BLOOD CULTURE ACCESSORIES
TABLE 22 BLOOD CULTURE ACCESSORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 INSTRUMENTS
TABLE 23 BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.3.1 AUTOMATED BLOOD CULTURE SYSTEMS
7.3.1.1 Automated blood culture systems is the largest & fastest-growing segment of the instruments market
TABLE 24 EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 25 AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3.2 SUPPORTING LABORATORY EQUIPMENT
TABLE 26 SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 27 SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3.2.1 Incubators
7.3.2.1.1 Incubators provide an optimal environment with respect to temperature, humidity, and oxygen level for microbial growth
TABLE 28 INCUBATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3.2.2 Colony counters
7.3.2.2.1 Colony counters increase direct image scanning and analysis capability
TABLE 29 COLONY COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3.2.3 Microscopes
7.3.2.3.1 Favorable funding scenario for R&D in microscopy to drive market growth
TABLE 30 MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3.2.4 Gram stainers
7.3.2.4.1 Gram staining offers relatively quicker results
TABLE 31 GRAM STAINERS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 SOFTWARE & SERVICES
7.4.1 NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET GROWTH
TABLE 32 BLOOD CULTURE SOFTWARE & SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
8 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY (Page No. - 76)
8.1 INTRODUCTION
TABLE 33 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
8.2 CULTURE-BASED TECHNOLOGIES
8.2.1 DRAWBACKS ASSOCIATED WITH TRADITIONAL CULTURE-BASED TECHNOLOGIES TO RESTRAIN MARKET GROWTH
TABLE 34 BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
8.3 MOLECULAR TECHNOLOGIES
TABLE 35 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 36 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
8.3.1 MICROARRAYS
8.3.1.1 Microarrays is the largest & fastest-growing segment of the molecular technologies market
TABLE 37 BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION, 2018-2025 (USD MILLION)
8.3.2 PCR
8.3.2.1 PCR is used with genetic markers to analyze pathogens directly from whole blood samples
TABLE 38 BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION, 2018-2025 (USD MILLION)
8.3.3 PNA-FISH
8.3.3.1 PNA-FISH tests help hospitals reduce time to pathogen identification
TABLE 39 BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION, 2018-2025 (USD MILLION)
8.4 PROTEOMICS
8.4.1 MALDI-TOF MS IS ASSOCIATED WITH HIGH ACCURACY
TABLE 40 EXAMPLES OF MALDI-TOF MS SYSTEMS
TABLE 41 BLOOD CULTURE TESTS MARKET FOR PROTEOMICS, BY REGION, 2018-2025 (USD MILLION)
9 BLOOD CULTURE TESTS MARKET, BY APPLICATION (Page No. - 83)
9.1 INTRODUCTION
TABLE 42 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
9.2 BACTEREMIA
9.2.1 RISING PREVALENCE OF SEPSIS TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 43 BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION, 2018-2025 (USD MILLION)
9.3 FUNGEMIA
9.3.1 INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS IS SUPPORTING THE GROWTH OF THIS SEGMENT
TABLE 44 BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION, 2018-2025 (USD MILLION)
9.4 MYCOBACTERIAL DETECTION
9.4.1 RISING NUMBER OF TB CASES—KEY FACTOR DRIVING MARKET GROWTH
TABLE 45 BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY REGION, 2018-2025 (USD MILLION)
10 BLOOD CULTURE TESTS MARKET, BY END USER (Page No. - 87)
10.1 INTRODUCTION
TABLE 46 BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2 HOSPITAL LABORATORIES
10.2.1 HOSPITAL LABORATORIES ARE THE LARGEST END USERS OF BLOOD CULTURE TESTS
TABLE 47 BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
10.3 REFERENCE LABORATORIES
10.3.1 REFERENCE LABORATORIES ARE THE FASTEST-GROWING END USERS OF BLOOD CULTURE TESTS
TABLE 48 BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
10.4 ACADEMIC RESEARCH LABORATORIES
10.4.1 INCREASING FOCUS ON THE R&D OF INNOVATIVE TESTS FOR BLOODSTREAM INFECTIONS TO DRIVE THE MARKET GROWTH
TABLE 49 BLOOD CULTURE TESTS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
10.5 OTHER LABORATORIES
TABLE 50 BLOOD CULTURE TESTS MARKET FOR OTHER LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
11 BLOOD CULTURE TESTS MARKET, BY REGION (Page No. - 92)
11.1 INTRODUCTION
TABLE 51 BLOOD CULTURE TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 16 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
TABLE 52 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 53 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 54 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 55 NORTH AMERICA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 56 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 57 NORTH AMERICA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 58 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 59 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 60 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 61 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 62 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.1 US
11.2.1.1 The US is the largest market for blood culture tests
TABLE 63 US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 64 US: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 65 US: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 66 US: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 67 US: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 68 US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 69 US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 70 US: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing incidence of bloodstream infections to drive market growth
TABLE 71 CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 72 CANADA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 73 CANADA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 74 CANADA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 75 CANADA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 76 CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 77 CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 78 CANADA: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3 EUROPE
TABLE 79 EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 80 EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 81 EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 82 EUROPE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 83 EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 84 EUROPE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 85 EUROPE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 86 EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 87 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 88 EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 89 EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany is the largest market for blood culture test products in Europe
TABLE 90 GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 91 GERMANY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 92 GERMANY: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 93 GERMANY: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 94 GERMANY: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 95 GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 96 GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 97 GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.2 UK
11.3.2.1 High burden of sepsis in the UK to drive the adoption of blood culture testing products
TABLE 98 UK: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 99 UK: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 100 UK: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 101 UK: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 102 UK: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 103 UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 104 UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 105 UK: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Rising geriatric population in France to drive the adoption of blood culture testing products
TABLE 106 FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 107 FRANCE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 108 FRANCE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 109 FRANCE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 110 FRANCE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 111 FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 112 FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 113 FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Sluggish growth in the Italian healthcare sector to hamper the market growth
TABLE 114 ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 115 ITALY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 116 ITALY: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 117 ITALY: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 118 ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 119 ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 120 ITALY: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Improving healthcare infrastructure to support market growth
TABLE 121 SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 122 SPAIN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 123 SPAIN: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 124 SPAIN: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 125 SPAIN: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 126 SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 127 SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 128 SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.6 REST OF EUROPE (ROE)
TABLE 129 ROE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 130 ROE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 131 ROE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 132 ROE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 133 ROE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 134 ROE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 135 ROE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 136 ROE: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 137 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 138 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 139 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 141 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 142 ASIA PACIFIC: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 143 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 144 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 145 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 146 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 147 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Japan is the largest market for blood culture tests in the APAC
TABLE 148 JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 149 JAPAN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 150 JAPAN: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 151 JAPAN: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 152 JAPAN: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 153 JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 154 JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 155 JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.2 CHINA
11.4.2.1 China is the fastest-growing market for blood culture tests
TABLE 156 CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 157 CHINA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 158 CHINA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 159 CHINA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 160 CHINA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 161 CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 162 CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 163 CHINA: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rising prevalence of infectious diseases to propel market growth
TABLE 164 INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 165 INDIA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 166 INDIA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 167 INDIA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 168 INDIA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 169 INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 170 INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 171 INDIA: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 172 ROAPAC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 173 ROAPAC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 174 ROAPAC: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 175 ROAPAC: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 176 ROAPAC: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 177 ROAPAC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 178 ROAPAC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 179 ROAPAC: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 FAVORABLE GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH
TABLE 180 LATAM: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 181 LATAM: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 182 LATAM: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 183 LATAM: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 184 LATAM: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 185 LATAM: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 186 LATAM: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 187 LATAM: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 188 LATAM: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 189 LATAM: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 INFRASTRUCTURAL DEVELOPMENTS TO SUPPORT MARKET GROWTH IN THE REGION
TABLE 190 MEA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 191 MEA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 192 MEA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 193 MEA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 194 MEA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 195 MEA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
TABLE 196 MEA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
TABLE 197 MEA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)
TABLE 198 MEA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 199 MEA: BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 147)
12.1 OVERVIEW
FIGURE 17 KEY DEVELOPMENTS IN THE BLOOD CULTURE TESTS MARKET
FIGURE 18 MARKET EVOLUTION FRAMEWORK
12.2 COMPETITIVE SITUATIONS & TRENDS
12.2.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020)
12.2.2 PRODUCT LAUNCHES & APPROVALS (2017-2020)
12.2.3 ACQUISITIONS (2017-2020)
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 150)
13.1 OVERVIEW
13.2 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
13.3 MARKET SHARE ANALYSIS
13.3.1 INTRODUCTION
FIGURE 19 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
13.4 COMPANY EVALUATION MATRIX
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE PLAYERS
13.4.4 PARTICIPANTS
FIGURE 20 MNM VENDOR DIVE COMPARISON MATRIX: BLOOD CULTURE TESTS MARKET
14 COMPANY PROFILES (Page No. - 153)
(Business overview, Products offered, Recent developments, MNM view)*
14.1 BECTON, DICKINSON AND COMPANY
FIGURE 21 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
14.2 BIOMÉRIEUX SA
FIGURE 22 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2019)
14.3 THERMO FISHER SCIENTIFIC, INC.
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
14.4 DANAHER CORPORATION
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
14.5 LUMINEX CORPORATION
FIGURE 25 LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)
14.6 BRUKER CORPORATION
FIGURE 26 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
14.7 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
FIGURE 27 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
14.8 IRIDICA (A SUBSIDIARY OF ABBOTT LABORATORIES)
FIGURE 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
14.9 T2 BIOSYSTEMS, INC.
FIGURE 29 T2 BIOSYSTEMS: COMPANY SNAPSHOT (2019)
14.10 BINDER GMBH
14.11 BIOBASE BIOTECH (JINAN) CO., LTD.
14.12 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD
14.13 BULLDOG BIO, INC.
14.14 AXIOM LABORATORIES
14.15 HIMEDIA LABORATORIES PVT. LTD.
14.16 ANAEROBE SYSTEMS, INC.
14.17 OPGEN, INC.
14.18 MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED
14.19 CARL ZEISS AG
14.20 NIKON CORPORATION
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
15 APPENDIX (Page No. - 182)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
The study involved four major activities in estimating the current market size for blood culture tests. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to, so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information as well as assess future prospects.
Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, opportunities, challenges, industry trends, and strategies adopted by key players.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood culture tests market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and to arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the fluoroscopy industry.
Report Objectives
- To define, describe, and measure the blood culture tests market by method, product, technology, application, end user and region
- To provide detailed information about the major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the blood culture tests market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market in North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa
- To strategically analyze the market structure and profile key players and their core competencies3 in the blood culture tests market
- To track and analyze competitive developments such as product launches, expansions, acquisitions, and partnerships & collaborations in the blood culture tests market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present blood culture tests market report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolio of each company (Top 3 companies)
Company Information
- Detailed analysis and profiling of additional market players (up to 3)
Get in-depth analysis of the COVID-19 impact on the Blood Culture Tests Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Blood Culture Tests Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Blood Culture Tests Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Blood Culture Tests Market